info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Research ArticleOpen Access

New Resveratrol Analogues for Potential Use in Diabetes and Cancer

Volume 6 - Issue 2

Keti Zeka*1,2, Randolph RJ Arroo2, Dritan Hasa2, Kenneth JM Beresford2 and Ketan C Ruparelia2

  • Author Information Open or Close
    • 1 Department of Haematology, University of Cambridge, UK
    • 2Faculty of Health and Life Sciences, De Montfort University, UK

    *Corresponding author: Keti Zeka, National Health Service Blood and transplant, Department of Haematology, University of Cambridge, Cambridge CB2 0PT, UK

Received: June 20, 2018;   Published: July 05, 2018

DOI: 10.26717/BJSTR.2018.06.001339

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Resveratrol is a well notorious compound that may play a role in the prevention of diabetes complications and different cancers. Along, resveratrol, a naturally occurring phytoalexin, is known to exert numerous beneficial effects in the organism. Isolation of resveratrol from plants, however, has been proved being difficult. Importantly, the bioavailability in the body is poor therefore capability is reduced and not enough resveratrol reaches the target organ. In this study we generated different methoxylated resveratrol analogues using Wittig reaction. trans stilbene obtained was 0.08 g and the cis one was 0.01 g. Additionally with the Horner-Witting method a yield of 0.15 g trans stilbene was obtained. By substituting the hydroxyl group with methoxy group at different positions on the aromatic rings, we could increase the efficacy and bioavailability of the trans form of resveratrol.

Keywords: Cancer; Diabetes; Horner Wittig Reaction; Resveratrol; Stilbene; Wittig Reaction

Abstract| Introduction| Materials and Method| Results and Discussion| Conclusion| Acknowledgement| References|